Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001897612-25-000193
Filing Date
2025-05-14
Accepted
2025-05-14 10:47:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7593
  Complete submission text file 0001897612-25-000193.txt   9523
Mailing Address 77 4TH AVENUE WALTHAM MA 02451
Business Address 77 4TH AVENUE WALTHAM MA 02451 781-663-6900
REVVITY, INC. (Subject) CIK: 0000031791 (see all company filings)

EIN.: 042052042 | State of Incorp.: MA | Fiscal Year End: 1229
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-18230 | Film No.: 25943468
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address 1307 POINT STREET BALTIMORE MD 21231
Business Address 1307 POINT STREET BALTIMORE MD 21231 000-000-0000
T. Rowe Price Investment Management, Inc. (Filed by) CIK: 0001897612 (see all company filings)

EIN.: 854328500 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SCHEDULE 13G/A